Clinical Trials Browser

OTHER × Neutropenia × trilaciclib × Clear all

NCT05578326 2025-07-08

Study of Trilaciclib and Lurbinectidin

Phase 2 Recruiting

Lung Neoplasms, Neutropenia, Small Cell Lung Carcinoma